Destination Breathe Easy: An In-Depth Look into The Patient’s Journey with Chronic Obstructive Pulmonary Disease

PROGRAM CHAIR & FACULTY

Carolyn L. Rochester, MD, FCCP
Professor of Medicine, Section of Pulmonary, Critical Care and Sleep Medicine
Director, Yale COPD Program
Yale School of Medicine
New Haven, CT

FEATURING

Linda
Brookfield, CT

PROGRAM OVERVIEW

This program has been developed to educate practitioners who care for patients with chronic obstructive pulmonary disease (COPD) on the emerging role of pro-inflammatory cytokines in COPD progression and treatment, improve their understanding of the evolving clinician trial landscape, and impart strategies to improve patient education and communication. The program provides a unique opportunity to hear the patient’s perspective on their disease journey, and from the treating physician on the clinical strategy that was implemented to manage disease symptoms.

TARGET AUDIENCE

This educational activity is specifically designed for US-based pulmonologists, pulmonary rehabilitation therapists, and thoracic surgeons that are involved in the diagnosis and management of patients with COPD.

LEARNING OBJECTIVES

Upon the completion of this program, attendees should be able to:

• Explain the roles of interleukins (IL)-4/13, IL-33, and other pro-inflammatory cytokine signaling pathways in the etiopathogenesis of COPD disease mechanism
• Discuss data from clinical studies investigating the clinical profiles of emerging therapies for the treatment of COPD
• Implement multidisciplinary, shared decision-making strategies to improve patient-specific communication and education throughout each step of the care continuum of COPD

JOINT ACCREDITATION STATEMENT

In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

PHYSICIAN CREDIT DESIGNATION STATEMENT

Med Learning Group designates this enduring activity for a maximum of 0.75 AMA PRA Category 1 Credit^TM. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.

NURSES (ANCC) CREDIT DESIGNATION

Med Learning Group designates this activity for a maximum of 0.75 ANCC contact hour.

DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS

All relevant financial relationships have been mitigated.

Content Review

The content of this activity was independently peer reviewed by a physician and nurse reviewer.

Individuals in Control of the Content of the Activity

The individuals in control of the content of this activity have reported the following financial relationships or relationships to products or devices they have with ineligible companies related to the content of this CE activity:

• Matthew Frese, MBA, General Manager of Med Learning Group, has nothing to disclose.
• Christina Gallo, SVP, Educational Development for Med Learning Group, has nothing to disclose.
• Surabhi Dangi-Garimella, Ph.D., Medical Director for Med Learning Group, has nothing to disclose.
• Lauren Welch, MA, VP, Accreditation and Outcomes for Med Learning Group, has nothing to disclose.
• Aimee Meissner, Accreditation and Outcomes Coordinator for Med Learning Group, has nothing to disclose.
• Lauren Bartunek, Senior Program Manager for Med Learning Group, has nothing to disclose.
• Heather Gee, Program Coordinator for Med Learning Group, has nothing to disclose.
• Michael Milano, MD, PhD, discloses that he receives UpToDate author royalties from Wolters Kluwer.
• Joan Duer-Hefele, RN, MA, CCRC, has nothing to disclose.

DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.

METHOD OF PARTICIPATION

There are no fees for participating and receiving CE credit for this activity. In order to obtain your certificate for the mentioned accreditation, participants need to successfully complete the associated pre/post activities and evaluation. Your certificate will be provided as a downloadable file.

DISCLAIMER

Med Learning Group makes every effort to develop CE activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.

For CE questions, please contact Med Learning Group at [email protected]

Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/

AMERICANS WITH DISABILITIES ACT

Event staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at [email protected]

RELEASED DATE: October 30, 2024
EXPIRATION DATE: October 30, 2025

Copyright © 2024 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.

PROGRAM CHAIR & FACULTY

Gerard Criner, MD
Professor and Founding Chair
Department of Thoracic Medicine and Surgery
Lewis Katz School of Medicine
Temple University
Philadelphia, PA

FEATURING

Ellen
Ridley Park, PA

PROGRAM OVERVIEW

This program has been developed to educate practitioners who care for patients with chronic obstructive pulmonary disease (COPD) on the emerging role of pro-inflammatory cytokines in COPD progression and treatment, improve their understanding of the evolving clinician trial landscape, and impart strategies to improve patient education and communication. The program provides a unique opportunity to hear the patient’s perspective on their disease journey, and from the treating physician on the clinical strategy that was implemented to manage disease symptoms.

TARGET AUDIENCE

This educational activity is specifically designed for US-based pulmonologists, pulmonary rehabilitation therapists, and thoracic surgeons that are involved in the diagnosis and management of patients with COPD.

LEARNING OBJECTIVES

Upon the completion of this program, attendees should be able to:

• Explain the roles of interleukins (IL)-4/13, IL-33, and other pro-inflammatory cytokine signaling pathways in the etiopathogenesis of COPD disease mechanism
• Discuss data from clinical studies investigating the clinical profiles of emerging therapies for the treatment of COPD
• Implement multidisciplinary, shared decision-making strategies to improve patient-specific communication and education throughout each step of the care continuum of COPD

JOINT ACCREDITATION STATEMENT

In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

PHYSICIAN CREDIT DESIGNATION STATEMENT

Med Learning Group designates this enduring activity for a maximum of 0.5 AMA PRA Category 1 Credit^TM. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.

NURSES (ANCC) CREDIT DESIGNATION

Med Learning Group designates this activity for a maximum of 0.5 ANCC contact hour.

DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS

All relevant financial relationships have been mitigated.

Content Review

The content of this activity was independently peer reviewed by a physician and nurse reviewer.

Individuals in Control of the Content of the Activity

The individuals in control of the content of this activity have reported the following financial relationships or relationships to products or devices they have with ineligible companies related to the content of this CE activity:

• Matthew Frese, MBA, General Manager of Med Learning Group, has nothing to disclose.
• Christina Gallo, SVP, Educational Development for Med Learning Group, has nothing to disclose.
• Surabhi Dangi-Garimella, Ph.D., Medical Director for Med Learning Group, has nothing to disclose.
• Lauren Welch, MA, VP, Accreditation and Outcomes for Med Learning Group, has nothing to disclose.
• Aimee Meissner, Accreditation and Outcomes Coordinator for Med Learning Group, has nothing to disclose.
• Lauren Bartunek, Senior Program Manager for Med Learning Group, has nothing to disclose.
• Heather Gee, Program Coordinator for Med Learning Group, has nothing to disclose.
• Michael Milano, MD, PhD, discloses that he receives UpToDate author royalties from Wolters Kluwer.
• Joan Duer-Hefele, RN, MA, CCRC, has nothing to disclose.

DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.

METHOD OF PARTICIPATION

There are no fees for participating and receiving CE credit for this activity. In order to obtain your certificate for the mentioned accreditation, participants need to successfully complete the associated pre/post activities and evaluation. Your certificate will be provided as a downloadable file.

DISCLAIMER

Med Learning Group makes every effort to develop CE activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.

For CE questions, please contact Med Learning Group at [email protected]

Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/

AMERICANS WITH DISABILITIES ACT

Event staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at [email protected]

RELEASED DATE: October 30, 2024
EXPIRATION DATE: October 30, 2025

Copyright © 2024 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.

PROGRAM CHAIR & FACULTY

Geoffrey Chupp, MD
Professor of Medicine, Section of Pulmonary, Critical Care and Sleep Medicine
Director, Yale Center for Asthma and Airways Disease (YCAAD)
Yale School of Medicine
Director, Pulmonary Function Laboratory, Yale New Haven Hospital
New Haven, CT

FEATURING

Denise
New Haven, CT

PROGRAM OVERVIEW

This program has been developed to educate practitioners who care for patients with chronic obstructive pulmonary disease (COPD) on the emerging role of pro-inflammatory cytokines in COPD progression and treatment, improve their understanding of the evolving clinician trial landscape, and impart strategies to improve patient education and communication. The program provides a unique opportunity to hear the patient’s perspective on their disease journey, and from the treating physician on the clinical strategy that was implemented to manage disease symptoms.

TARGET AUDIENCE

This educational activity is specifically designed for US-based pulmonologists, pulmonary rehabilitation therapists, and thoracic surgeons that are involved in the diagnosis and management of patients with COPD.

LEARNING OBJECTIVES

Upon the completion of this program, attendees should be able to:

• Explain the roles of interleukins (IL)-4/13, IL-33, and other pro-inflammatory cytokine signaling pathways in the etiopathogenesis of COPD disease mechanism
• Discuss data from clinical studies investigating the clinical profiles of emerging therapies for the treatment of COPD
• Implement multidisciplinary, shared decision-making strategies to improve patient-specific communication and education throughout each step of the care continuum of COPD

JOINT ACCREDITATION STATEMENT

In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

PHYSICIAN CREDIT DESIGNATION STATEMENT

Med Learning Group designates this enduring activity for a maximum of 0.75 AMA PRA Category 1 Credit^TM. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.

NURSES (ANCC) CREDIT DESIGNATION

Med Learning Group designates this activity for a maximum of 0.75 ANCC contact hour.

DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS

All relevant financial relationships have been mitigated.

Content Review

The content of this activity was independently peer reviewed by a physician and nurse reviewer.

Individuals in Control of the Content of the Activity

The individuals in control of the content of this activity have reported the following financial relationships or relationships to products or devices they have with ineligible companies related to the content of this CE activity:

• Matthew Frese, MBA, General Manager of Med Learning Group, has nothing to disclose.
• Christina Gallo, SVP, Educational Development for Med Learning Group, has nothing to disclose.
• Surabhi Dangi-Garimella, Ph.D., Medical Director for Med Learning Group, has nothing to disclose.
• Lauren Welch, MA, VP, Accreditation and Outcomes for Med Learning Group, has nothing to disclose.
• Aimee Meissner, Accreditation and Outcomes Coordinator for Med Learning Group, has nothing to disclose.
• Lauren Bartunek, Senior Program Manager for Med Learning Group, has nothing to disclose.
• Heather Gee, Program Coordinator for Med Learning Group, has nothing to disclose.
• Michael Milano, MD, PhD, discloses that he receives UpToDate author royalties from Wolters Kluwer.
• Joan Duer-Hefele, RN, MA, CCRC, has nothing to disclose.

DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.

METHOD OF PARTICIPATION

There are no fees for participating and receiving CE credit for this activity. In order to obtain your certificate for the mentioned accreditation, participants need to successfully complete the associated pre/post activities and evaluation. Your certificate will be provided as a downloadable file.

DISCLAIMER

Med Learning Group makes every effort to develop CE activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.

For CE questions, please contact Med Learning Group at [email protected]

Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/

AMERICANS WITH DISABILITIES ACT

Event staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at [email protected]

RELEASED DATE: October 30, 2024
EXPIRATION DATE: October 30, 2025

Copyright © 2024 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.